BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 1, 2010
View Archived Issues
Small molecules activating apoptotic procaspases identified
Read More
Novotyr Therapeutics presents IGF-1R inhibitors as antineoplastic agents
Read More
Studies demonstrate prediction of recurrence with Oncotype DX in colon cancer
Read More
Ark puts development of Vitor on hold following results from phase III study in NSCLC
Read More
Teva and AWD.pharma claim KCNQ channel activators for the treatment of pain
Read More
Achillion selects ACH-2684 as lead clinical candidate in hepatitis C infection program
Read More
Pfizer presents update on pipeline following acquisition of Wyeth in October 2009
Read More
GTC provides update for recombinant human Factor VIIa
Read More
Oncolytic choline kinase inhibitor TCD-717 to enter clinical development
Read More
Roche identifies selective P2X3 antagonist: RO-85
Read More
Arena discloses S1P1 receptor agonists for autoimmune/inflammatory conditions
Read More
DMI Life Sciences describes novel PKB/Akt and MMP-9 inhibitors
Read More
Novel beta-agonists for asthma therapy claimed by Gilead
Read More
SK Chemicals presents ALK4 and 5 inhibitors for the treatment of fibrosis
Read More
IDSMB recommends continuation of Basilea's phase III trial of isavuconazole
Read More
Genfit reports results from completed phase II trial of GFT-505
Read More
GTAC completes review of ReNeuron's supplemental preclinical data package for ReN-001
Read More
Amarin presents update on MARINE and ANCHOR phase III clinical trials of AMR-101
Read More
Spectrum receives payments from Nippon and Handok under agreements for EOquin
Read More
Diamyd to file for market approval of Diamyd diabetes vaccine in 2011
Read More
Watson acquires Eden Biodesign for approximately USD 15 million
Read More
Daiichi Sankyo submits NDA in Japan for long-acting CS-8958
Read More
European Commission approves Merck's MAA for fertility treatment Elonva
Read More
Phosphagenics reports results from phase Ib study of its transdermal oxycodone patch
Read More
FDA says Theravance's response to complete response letter for telavancin incomplete
Read More
Final phase II data support safety of picoplatin as alternative to oxaliplatin in metastatic CRC
Read More